I-Shou University

Nina Tsao

Chih-Feng Kuo

Chih-Hsin Hung

The present invention relates to a vaccine composition againstinfection comprising an amino acid sequence having C-terminal fragment of streptococcal pyrogenic exotoxin B, and a pharmaceutical acceptable adjuvant.

[object Object]

A therapy or prophylaxis ofinfections with a lytic bacteriophage specifically against, provides a lytic bacteriophage (DSM 24329) to ainfected organism for the sake of relieving the serious complications of liver abscesses and bacteremia, and the high mortality rate ofinfections in Taiwan.

A newly isolated lytic bacteriophage specifically against, deposited at DSMZ-Deutsche Sammlung von Mikroorganismen and Zellkulturen with deposit number (DSM 24329), shows broad host ranges and lytic effects onisolated from Taiwan under either in vivo or in vitro models.

Growing community of inventors

Kaohsiung, Taiwan

Nina Tsao